• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Dementia Management Update"

    (session captured at the GAPNA 2018 Annual Conference)

    For September/October 2019 - Get Your Free CNE Now!

Parkinson's Disease: Update on Medication Management

GAPNA member Ann Kriebel-Gasparro, DrNP, FNP-BC, GNP-BC recently completed the Edmond J. Safra Visiting Nurse Scholars Program in Parkinson's Disease at the University of Pennsylvania, Pennsylvania Hospital Parkinson's Disease Clinic.

As part of the program project, she submitted an abstract for the Journal of Nurse Practitioners special Pharmacology issue. This freely accessable article, “Parkinson's Disease: Update on Medication Management” was published online in March 2016.

From the article:


  • Parkinson’s disease is reviewed to provide an understanding of the pharmacologic therapies used to treat motor and nonmotor symptoms.
  • Levadopa and carbidopa are the gold standard of treatment; doses, side effects, and formulations are discussed.
  • The different classes of medications used to treat Parkinson’s disease, and those used to mitigate side effects of treatment and Parkinsonism, are reviewed.
  • An overview of deep brain stimulation is provided, which is often used in the advanced stages of the disease to decrease medication doses.

Read the full article.

Additonal information

Read more about Ann Kriebel-Gasparro, DrNP, FNP-BC, GNP-BC, in the Tell Us About It! section of the GAPNA Website.

Related Topic 1: 

GAPNA Newsletter Issue: